Open AccessLysozyme nephropathy in chronic myelomonocytic leukemia
Author(s) -
Patel Ami B.,
Miles Rodney R.,
Deininger Michael W.
Publication year - 2019
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2188
Subject(s) - medicine , lysozyme , chronic myelomonocytic leukemia , nephropathy , immunology , cancer research , biochemistry , endocrinology , bone marrow , myelodysplastic syndromes , biology , diabetes mellitus
Lysozyme nephropathy is a frequently unrecognized cause of renal disease in chronic myelomonocytic leukemia and may serve as a novel indication for treatment in this patient population. We demonstrate that in newly diagnosed CMML patients, plasma lysozyme levels are positively correlated with both absolute monocyte count and serum creatinine.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom